The influenza A virus matrix 1 protein (M1) shuttles between the cytoplasm and the nucleus during the viral life cycle and plays an important role in the replication, assembly, and budding of viruses. Here, a leucine-rich nuclear export signal (NES) was identified specifically for the nuclear export of the M1 protein. The predicted NES, designated the Flu-A-M1 NES, is highly conserved among all sequences from the influenza A virus subtype, but no similar NES motifs are found in the M1 sequences of influenza B or C viruses. The biological function of the Flu-A-M1 NES was demonstrated by its ability to translocate an enhanced green fluorescent protein (EGFP)-NES fusion protein from the nucleus to the cytoplasm in transfected cells, compared to the even nuclear and cytoplasmic distribution of EGFP. The translocation of EGFP-NES from the nucleus to the cytoplasm was not inhibited by leptomycin B. NES mutations in M1 caused a nuclear retention of the protein and an increased nuclear accumulation of NEP during transfection. Indeed, as shown by rescued recombinant viruses, the mutation of the NES impaired the nuclear export of M1 and significantly reduced the virus titer compared to titers of wild-type viruses. The NES-defective M1 protein was retained in the nucleus during infection, accompanied by a lowered efficiency of the nuclear export of viral RNPs (vRNPs). In conclusion, M1 nuclear export was specifically dependent on the Flu-A-M1 NES and critical for influenza A virus replication.
I
nfluenza A virus is a negative-strand RNA virus composed of eight segmented strands of an RNA genome (21) . The viral structural components include the viral envelope, the transmembrane proteins (hemagglutinin [HA] , neuraminidase [NA] , and M2), M1, NS2, and the viral ribonucleoprotein (vRNP), which contains viral RNA (vRNA), nucleoprotein (NP), and viral polymerase proteins (PB1, PB2, and PA) (44) .
M1 is the most abundant protein in the virus particle, sustaining the virion structure by forming a shell connecting the viral envelope and the nucleocapsid (40) . M1 is synthesized in the late stages of infection, shuttles between the nucleus and the cytoplasm (45) , and plays multiple roles in various steps of the influenza virus life cycle.
Newly synthesized M1 is transported from the cytoplasm into the nucleus via a nuclear localization signal (NLS) located in its N-terminal domain (residues 101 to 105) (38, 48) . In the nucleus, M1 is involved in the blocking of the transcription of viral mRNA by binding to vRNPs (4, 49) . Aside from terminating viral transcription, M1 also plays an important role in the nuclear export of vRNPs. Indeed, the nuclear presence of M1 is required for vRNPs to be transported to the cytoplasm (8, 27) , where the vRNPs are subsequently transported to the budding site. First, M1 binds to histones in the nucleus (51) and may participate in releasing vRNPs from the nuclear matrix. Second, M1 likely bridges the NEP and vRNPs, forming a complex that is in turn exported from the nucleus by the nuclear export signal (NES) located in the N terminus of NEP (residues 12 to 21) (5). NEP is crucial for the nuclear export of vRNPs (30, 32) and associates with vRNPs through M1 in the virions (47) . Previous in vitro studies have also demonstrated that the NLS-containing area interacts with NEP (1, 39) and that the middle domain of M1 binds to vRNPs (4, 11, 31) .
During late time points of infection, M1 is exported from the nucleus (45) and plays important roles in the cytoplasm. Binding between M1 and vRNPs in the cytoplasm blocks the reentry of vRNPs into the nucleus (7, 27) , which is important for efficient viral assembly. M1 is also involved in the processes of viral assembly (3, 6, 33) and budding, and it affects virus morphology (9, 13, 34) . Indeed, M1 is hypothesized to be critical for gathering viral components at the budding site due to its ability to bind to the lipid membrane and the cytoplasmic tails of viral envelope glycoproteins (2) as well as to vRNPs.
It has been shown that the matrix proteins from some enveloped RNA viruses shuttle between the nucleus and the cytoplasm during viral replication and play important roles in virus budding and assembly, e.g., the matrix proteins of Nipah virus and respiratory syncytial virus. Both of these proteins are exported from the nucleus via a leucine-rich NES (15, 43) . However, it is unclear how the M1 protein of influenza virus is exported from the nucleus. Here, we identified a leucine-rich, leptomycin B (LMB)-insensitive NES in influenza A virus M1. Furthermore, M1 nuclear export was specifically dependent on this NES and critical for influenza A virus replication.
MATERIALS AND METHODS

Cells and reagents.
Human embryonic kidney 293 (293T), human alveolar epithelial (A549), HeLa, mouse NIH 3T3 and Madin-Darby canine kidney epithelial (MDCK) cell lines were grown in Dulbecco's modified Eagle medium (DMEM; Gibco) supplemented with 10% fetal bovine serum (FBS; Gibco) at 37°C in 5% CO 2 . Lipofectamine reagent was purchased from Invitrogen. MG132 was purchased from Calbiochem. Di-methyl sulfoxide (DMSO), polyethyleneimine (PEI), polyethylene glycol 8000 (PEG 8000), and cycloheximide were purchased from Sigma. Leptomycin B (LMB) was purchased from Tocris Bioscience.
Plasmids and virus. A 12-plasmid influenza virus rescue system was kindly provided by George F. Gao. To construct plasmids encoding the enhanced green fluorescent protein (EGFP)-NES fusion protein and the wild-type (WT) or mutant M protein fused with EGFP, the sequence encoding the Flu-A-M1 NES was artificially synthesized, and the WT and mutant M1 coding sequences were amplified by PCR and inserted between the BamHI and XhoI sites in the pEGFP-C1 vector, respectively. To construct pCMV-Myc-NEP, the open reading frames (ORFs) encoding NEP of the WSN strain of influenza A virus were amplified by reverse transcription (RT)-PCR using total RNA extracted from infected 293T cells as the template and then inserted into the pCMV-Myc vector between the EcoRI and XhoI sites. The primers used to amplify WT and mutant M1 and NEP coding sequences were as follows: M1-1 (5=-TAAC TCGAGCTATGAGTCTTCTAACCGAGG-3=), M1-68 (5=-TAAGGATC CCACGGTGAGCGTGAACACAAATCC-3=), M1-69 (5=-TAACTCGAG CTCCCAGTGAGCGGGGACTG-3=), M1-96 (5=-TAACTCGAGCTAAA GCAGTTAAACTGTATAGG-3=), M1-105 (5=-TAAGGATCCTCACCTC TTAAGCTTCCTATACAG-3=), M1-252 (5=-TAAGGATCCTCACTTGA ATCGTTGCATC-3=), NEP-1 (5=-ACAAGAATTCGGATGGATCCAAA CACT-3=), and NEP-2 (5=-ACAACTCGAGTTAAATAAGCTGAAA-3=). The plasmids encoding EGFP-NES mutants (I59A, L60A, G61A, V63A, L66A, T67A, V68A, I59A/V63A, and I66A/V68A), the plasmids encoding Flag-M1 mutants (including L66A, V68A, and I66A/V68A), and the plasmid encoding the M gene mutant (I66A/V68A), which were used for virus rescue, were generated with a QuikChange II site-directed mutagenesis kit (Stratagene). The ORF of simian virus 40 (SV40) large T antigen was amplified with primers SV40LT-F (5=-ATGGTACCATGGATAAAGTTT TAAACAG) and SV40LT-linker-R (5=-ATGGATCCACCTGAACCACC AGAACCTCCTGTTTCAGGTTCAGGGG) and inserted into a modified pcDNA 3.0 vector. The sequence coding for the putative NES was cloned into the C terminus of the ORF of SV40 LT. All of the constructs were verified by DNA sequencing. The influenza viruses used in this study were artificially generated from the 12-plasmid influenza virus rescue system.
Antibodies. Mouse anti-M1 monoclonal antibody was generated as described previously (18) . Rabbit anti-NP polyclonal antibody was produced by immunizing a mouse with purified His-NP, as described previously (24) . Mouse anti-Flag monoclonal antibody and rabbit anti-Myc monoclonal antibody were purchased from Santa Cruz Biotechnology. Goat anti-rabbit IgG conjugated to tetramethyl rhodamine isocyanate (TRITC) and goat anti-mouse IgG conjugated to fluorescein isothiocyanate (FITC) were obtained from Zhongshan Golden Bridge Biotechnology.
Transfection and infection. 293T, HeLa, and A549 cells were grown in a 24-well cell culture cluster with a cover slide in each well. Transfection was performed by using PEI or Lipofectamine reagent according to the manufacturer's instructions. At 6 h posttransfection, the medium containing the mixture of plasmids and transfection reagent was replaced with fresh DMEM supplemented with 10% FBS.
For infection, the cells were incubated with influenza virus for 1 h at 37°C. The cells were then washed with phosphate-buffered saline (PBS) and incubated in DMEM with or without FBS for the indicated times at 37°C in 5% CO 2 .
Generation of recombinant influenza viruses with the 12-plasmid virus rescue system. 293T and MDCK cells were mixed in a 5:1 ratio and grown on a 60-mm-diameter dish in DMEM supplemented with 10% FBS until the cells reached 90% confluence. The culture medium was then replaced with fresh DMEM containing 2% FBS. After incubation for 1 h, a mixture of 1 g each of the 12 plasmids in the virus rescue system was transfected into the cells by using Lipofectamine reagent according to the manufacturer's instructions. Six hours later, the medium containing the mixture of plasmids and Lipofectamine reagent was replaced with DMEM supplemented with 0.1% FBS and 2 g/l L-1-tosylamide-2-phenylethyl chloromethyl ketone (TPCK)-treated trypsin. The cells were further incubated for 42 h at 37°C in 5% CO 2 , and the supernatant containing the generated recombinant virus was harvested and centrifuged at 200 ϫ g for 10 min to remove contaminating cells.
Plaque assay. MDCK cells were grown in a 12-well cell culture cluster to produce a confluent monolayer. After the cells were washed with PBS, they were inoculated with 10-fold serial dilutions of virus and incubated at 37°C for 1 h for viral absorption. Unabsorbed virus was removed by washing the cells with PBS, and 1 ml DMEM supplemented with 2 ng/l TPCK-treated trypsin and 1.5% agarose was then added to each well. After incubation for 72 h at 37°C in 5% CO 2 , the number of plaques in each well was counted, and the virus concentration was determined in PFU/ml. Fluorescent focus assay. MDCK cells were grown in a 24-well cell culture cluster with a removable 15-mm-diameter cover slide placed at the bottom of each well. When they reached 90% confluence, the cells were washed with PBS and inoculated with 10-fold serial dilutions of virus. After viral absorption at 37°C for 1 h, unabsorbed virus was removed by washing the cells with PBS. The cells were further incubated at 37°C in 5% CO 2 for 8 h. The cover slide in each well was then collected and fixed in 4% paraformaldehyde in PBS. An immunofluorescence microscopy assay was performed with an antibody against NP and a TRITC-conjugated antibody against rabbit IgG. For each slide, cells labeled with the fluorescent antibody were counted. The fluorescent focus units (FFU) per ml were determined.
Heterokaryon assay. A heterokaryon assay was performed as described previously (22) . Briefly, the plasmid encoding the SV40 LT-NES fusion protein was transfected into 293T cells. Twenty-four hours after transfection, the transfected 293T cells were mixed with untransfected NIH 3T3 cells and seeded into a 24-well cell culture plate with glass coverslips inside. The cocultured cells were maintained at 37°C for 18 h. The cells were subsequently treated with cycloheximide at 50 mg per ml for 30 min and 50% PEG 8000 in DMEM for 2 min and further incubated for 2.5 h in DMEM containing 10% fetal bovine serum and cycloheximide at 50 mg per ml at 37°C before being fixed and stained with 4=,6-diamidino-2-phenylindole (DAPI) and antibody against the Flag tag.
RESULTS
Influenza A virus M1 contains a leucine-rich NES.
Sequence analysis of the M1 protein of influenza A virus revealed a sequence motif resembling a leucine-rich NES (16) containing four critical hydrophobic amino acids (i.e., I59, V63, L66, and V68) and was named the Flu-A-M1 NES (Table 1) . To examine if this predicted Flu-A-M1 NES is biologically functional, the NES sequence was first fused to the C terminus of EGFP. In 293T cells, the EGFP-NES fusion protein was located predominantly in the cytoplasm at 16 h after transfection, compared with only the EGFP protein, which was evenly distributed in the nucleus and the cytoplasm (Fig. 1A) , demonstrating that the Flu-A-M1 NES caused the nuclear export 
No match found a The key residues in each NES are in boldface type. The Flu-A-M1 NES was composed of residues I59 to V68. NES, nuclear export signal; X, any amino acid residue.
of EGFP-NES. The previously reported NES (residues 12 to 21) of NEP (NEP-12-21) of influenza virus (30, 32) was fused to EGFP as a positive control. EGFP-NEP-12-21 was also predominantly distributed in the cytoplasm. The Flu-A-M1 NES was also cloned into the pEGFP-N1 vector, but the distribution of the NES-EGFP fusion protein was the same as that of EGFP, being evenly localized between the nucleus and cytoplasm (data not shown), indicating that the NES had no biological function when fused to the N terminus of EGFP. LMB is a nuclear export inhibitor that targets chromosome region maintenance 1 (CRM1), which is a cellular export receptor of leucine-rich NESs (12, 20) . To determine whether LMB inhibited the nuclear export of the EGFP-NES fusion protein, 293T cells transfected with the vector pEGFP-C1, pEGFP-C1-NES, or pEGFP-C1-NEP-12-21 were treated with 11 nM LMB for 3 h. In the LMB-treated group, neither the distribution of EGFP nor that of EGFP-NES was affected, whereas the distribution of EGFP-NEP-12-21 was changed from predominantly cytoplasmic to evenly distributed between the nucleus and the cytoplasm, showing that the Flu-A-M1 NES was not LMB sensitive.
Since the Flu-A-M1 NES was not sensitive to LMB, the possibility that EGFP-NES was not even transported into the nucleus cannot be excluded. To further confirm the function of the putative NES, the Flu-A-M1 NES was fused to the C terminus of SV40 LT after a short linker. SV40 LT is located in the nucleus (37) and cannot shuttle between the nucleus and cytoplasm (22) . The SV40 LT-NES fusion protein was also located in the nucleus of the transfected 293T cells. To test whether the SV40 LT-NES fusion protein can shuttle between the nucleus and cytoplasm due to the NES, transfected 293T cells were fused with untransfected NIH 3T3 cells in the presence of cycloheximide. As expected, the SV40 LT-NES fusion protein was transported from the nucleus of 293T cells to the nucleus of NIH 3T3 cells (Fig. 1B) , demonstrating the nuclear exporting function of the putative Flu-A-M1 NES.
Alanine substitution analysis was performed to test the importance of the predicted key hydrophobic residues in the Flu-A-M1 NES ( Table 2 ). The EGFP-NES fusion protein exhibited a cytoplasmic distribution in 92.0% Ϯ 2.6% of the transfected 293T cells. However, a cytoplasmic distribution of the EGFP-NES mutants was observed for only 44.0% Ϯ 18.0% to 64.7% Ϯ 4.5% of the transfected cells, indicating that the I59A, V63A, L66A, or V68A mutations of the Flu-A-M1 NES impair the function of the NES. To further evaluate the function of the Flu-A-M1 NES, combined alanine substitutions of the L66 and V68 residues were introduced into the EGFP-NES fusion protein. As expected, this EGFP-NES mutant exhibited a cytoplasmic distribution in only 13.7% Ϯ 4.0% of the transfected cells, suggesting that the cytoplasmic distribution of EGFP-NES was specifically caused by the NES and that combined alanine substitutions of the L66 and V68 residues strongly impaired the function of the NES.
The Flu-A-M1 NES is essential for the nuclear export of fulllength M1. M1 shuttles between the nucleus and the cytoplasm during virus infection and is involved in the nuclear export of vRNPs by connecting NEP and vRNPs. The putative NES and the NLS are located in the N-terminal domain and the middle domain of M1, respectively. The positively charged NLS-containing residues interact with NEP, while the middle domain of M1, from N87 to M165, binds to vRNPs (1, 31, 39) (Fig. 2A) .
To examine if the Flu-A-M1 NES mediates the nuclear export of full-length M1 and to further confirm the importance of the L66 and V68 residues in M1, the WT or mutant M1 protein was fused to the C terminus of EGFP (Fig. 2B) . EGFP fused to residues 1 to 68 of M1 (EGFP-M1-1-68), which contained the predicted NES, was located predominantly in the cytoplasm (Fig. 2C) , and EGFP-M1-96-105, which contained the previously reported NLS, ) were cloned into a Flag-tag-containing pcDNA 3.0 vector and linked by a short linker sequence. The plasmid encoding the SV40 LT-NES fusion protein was transfected into 293T cells. Twenty-four hours after transfection, the transfected 293T cells (arrowheads) were mixed with untransfected NIH 3T3 cells (arrows) and seeded into a 24-well cell culture plate with glass coverslips inside. The cocultured cells were maintained at 37°C for 18 h. The cells were subsequently treated with cycloheximide at 50 mg per ml for 30 min and 50% polyethylene glycol 8000 (PEG 8000) in DMEM for 2 min, further incubated for 2.5 h in DMEM containing 10% fetal bovine serum and cycloheximide at 50 mg per ml at 37°C before being fixed and stained with DAPI and antibody against the Flag tag, and imaged with a confocal laser scanning fluorescence microscope (Olympus LSCMFV500).
was located predominantly in the nucleus, demonstrating that the two domains involved in nuclear-cytoplasmic transport were both functional. EGFP-M1-69-252, in which the putative NES was deleted, was located completely in the nucleus. EGFP-M1-L66A/ V68A, which contained the NLS and the mutated NES, also showed an obvious nuclear accumulation, demonstrating that the putative NES was required for the nuclear export of M1 and that the alanine substitution of L66 and V68 impaired the nuclear export of full-length M1. This result was also confirmed by fractionation experiments with cells transfected with the indicated constructs. Compared with the WT or mutant M1 protein in the nuclear components in each group, the amount of cytoplasmic M1 was obviously reduced due to the mutation or deletion of the NES (Fig. 3) .
The nuclear export of M1 contributes to the replication of influenza A virus. Recombinant influenza virus was generated by cotransfecting 293T cells with the 12-plasmid virus rescue system described in Materials and Methods. Combined L66 and V68 alanine substitutions were introduced into the plasmid carrying the M gene of influenza virus. The virus titer of the recombinant M1 (Fig. 4B) , showing that the reduced amount of the recombinant mutant virus was not caused by the titration method.
To further determine the effect of mutations within the Flu-A-M1 NES on virus replication, A549 cells were inoculated with the recombinant WT and mutant viruses at a multiplicity of infection (MOI) of 0.001. The infectious virus particles in the culture supernatant were then titrated via a plaque assay on MDCK cells at various times postinfection (p.i.) (Fig. 4C) . Our results demonstrated that the growth rate of the mutant virus was greatly impaired. The maximum titer of the mutant virus in the multiple growth cycles was about 200-fold lower than that of the WT virus.
The NES-deleted M1 protein causes the nuclear retention of NEP. NEP of influenza virus was reported previously to play an important role in the nuclear export of vRNP. In a recent model, M1 was suggested to be the mediator that bridges the NEP and the vRNP, which was based on a report that the N-terminal domain of NEP contains an NES (residue 12 to 21), the C-terminal domain of NEP is able to bind to the NLS-containing area of M1, and the middle domain of M1 binds to vRNP (5) . Therefore, we wondered whether NEP could facilitate the nuclear export of the NES-deleted M1 protein. A construct encoding the EGFP-tagged WT protein or the M1-69-252 protein and a construct encoding Myctagged NEP were cotransfected into 293T cells. When Myc-NEP was coexpressed with WT EGFP-M1, Myc-NEP showed stronger cytoplasmic staining than nuclear staining, and EGFP-M1 was evenly distributed between the nucleus and the cytoplasm. However, EGFP-M1-69-252 was still trapped in the nucleus in the presence of Myc-NEP, and surprisingly, even a portion of Myc-NEP showed a nuclear distribution colocalized with EGFP-M1-69-252 (Fig. 5) , indicating that the Flu-A-M1 NES was required for the nuclear export of the presumed NEP-M1 complex under transfection conditions.
Substitutions of L66A and V68A in the M gene impaired the nuclear export of M1 and NP during virus infection. To determine if the mutant M1 protein was retained in the nucleus during virus infection, A549 cells were infected with the recombinant WT or mutant influenza virus at an MOI of 0.01 (Fig. 6) . At 12 h p.i., WT M1 was located predominantly in the cytoplasm, but the nuclear staining of the Flu-A-M1 NES mutant M1 protein was obvious, indicating that WT M1 was transported to the cytoplasm at late times of infection but that the NES mutant M1 protein accu-
FIG 3
The Flu-A-M1 NES is required for the nuclear export of full-length M1.
293T cells were transfected with constructs encoding the WT or mutant M1 protein fused with EGFP. The cells were harvested 24 h later and separated into a nuclear fraction (N) and a cytoplasmic fraction (C). The amount of the indicated proteins in each fraction was then tested by Western blotting with a monoclonal antibody against M1. In the cells infected with the WT virus, NP was distributed predominantly in the cytoplasm, like the distribution of WT M1, while in the cells infected with the Flu-A-M1 NES mutant virus, NP was still detected in the nucleus, suggesting that the nuclear export of NP or vRNP was affected by the nuclear retention of the NES mutant M1 protein.
DISCUSSION
The amino acid sequences of the M1 proteins of known influenza A virus subtypes, available from the Influenza Virus Sequence Database of the NCBI (http://www.ncbi.nlm.nih.gov/genomes /FLU/Database/nph-select.cgi?goϭdatabase), were aligned. We found that the Flu-A-M1 NES is highly conserved among all the influenza A virus subtypes analyzed (data not shown). However, no similar NES consensus sequence in the M1 proteins of influenza B or C viruses was identified, although M1 is highly conserved among influenza B and C viruses (23, 42) . Influenza C virus M1 is transported to the nucleus during virus replication (41) and is involved in virus morphology (29) , while influenza B virus M1 affects viral growth and virulence in mice (28) . The nuclear-cytoplasmic transport of M1 from influenza B and C viruses has not been studied in detail. Further investigation is needed to determine how influenza B and C virus M1 proteins are exported from the nucleus without leucine-rich NESs. One of the most significant differences among influenza A, B, and C viruses is that influenza A virus uses avians as a natural reservoir, while influenza B and C viruses infect only mammals (17, 28) . It is possible that the lack of a leucine-rich NES in M1 proteins from influenza B and C viruses is evolutionarily relevant.
Virion-originated M1 is released into the cytoplasm from virions at an early stage of infection and is imported into the nucleus (26) . The M1 protein that is newly synthesized during the late stages of infection is imported into the nucleus, and this process is mediated by the NLS in the N-terminal domain of M1 (residues 101 to 105) (48) and plays an important role in the nuclear export of vRNPs (8) . Nevertheless, neither M1 from virions nor newly synthesized M1 is completely imported into the nucleus during infection. A portion of M1 is distributed in the cytoplasm, perhaps because (i) the interaction of M1 with cytoskeletal elements, the cell membrane, or viral glycoproteins retains M1 in the cytoplasm (2, 3, 35) or (ii) M1 is continuously shuttling between the nucleus and the cytoplasm. During the late period of infection, nuclear M1 is ultimately exported to the cytoplasm (45) . However, the mechanism of the nuclear export of M1 was not clear.
M1 does not shuttle between the nucleus and cytoplasm by free diffusion, because newly synthesized M1 homogeneously oligomerizes into a continuous series of complexes immediately after expression in vivo, ranging from dimers to multimers, the molecular mass of which obviously exceeds the upper limit (40 kDa) for diffusion through the nuclear pore (50) . Additional evidence against free diffusion is that NLS-defective M1 is not imported into the nucleus, demonstrating that the nuclear import of M1 is mediated by the NLS (48) . Like the nuclear import of M1, nuclear export is likely mediated by an NES possessed by M1 or a protein that interacts with M1, such as NEP (5) .
In the present study, we identified a leucine-rich NES in M1 which is critical for the nuclear export of M1. The mutation or deletion of the putative NES clearly impaired the nuclear export of M1, suggesting that the Flu-A-M1 NES was required for the nuclear-cytoplasmic transport of M1. NEP is a candidate adaptor for the nuclear export of M1 because NEP contains an NES (30, 32) and binds to M1 both in vitro and in vivo (1, 39, 47) . To test whether the nuclear export of M1 was also mediated by NEP, 293T cells were cotransfected with NEP and M1-69-252. M1-69-252 was still localized predominantly in the nucleus, and even some NEP was colocalized with nuclear-trapped M1-69-252, indicating that the Flu-A-M1 NES was required for the nuclear export of the NEP-M1 complex and that the NES of NEP was spatially masked in the NEP-M1 complex. During infection, although the nuclear accumulation of NES-defective M1 was obvious, the mutant M1 protein was also detected in the cytoplasm. The cytoplasmic mutant M1 protein could be spontaneously accumulated in the cytoplasm after synthesis; exported from the nucleus, mediated by the mutated NES, which was not completely destroyed by the alanine substitution of L66A and V68A; or exported from the nucleus in the form of an NEP-M1-vRNP complex, mediated by the NES of NEP, because the NES of NEP was peculated exposed again as the steric hindrance effect of M1 was removed by the interaction with vRNP.
The intracellular distribution of M1 was not sensitive to LMB treatment during infection (14, 25) . In accordance with this, the Flu-A-M1 NES was not sensitive to LMB either. The leucine-rich NESs are commonly composed of a core of leucine or large hydrophobic residues, which could be recognized by CRM1. Most of the leucine-rich NESs, including the first reported one, which was identified in the human immunodeficiency virus (HIV) Rev protein, could be inhibited by LMB, which covalently bound to residue C529 of CRM1 (19) . However, there were also a few proteins containing leucine-rich NESs which were not sensitive to LMB treatment, such as the N protein of canine distemper virus (CDV) and human receptor-interacting protein 3 (RIP3) (36, 46) . The Flu-A-M1 NES was not sensitive to LMB, maybe because LMB could not block the interaction of CRM1 and the Flu-A-M1 NES or perhaps because the Flu-A-M1 NES together with the two above-mentioned LMB-insensitive NESs used cellular adapters other than CRM1. According to a resolved crystal structure of the N-terminal domain of M1 (Protein Data Bank [PDB] accession no. 1AA7), the first seven residues of the putative NES are in the C terminus of helix 4 of M1, and the last three residues of the putative NES, including the critical residues L66 and V68, are located in the following loop structure, which is exposed to the surface of the molecule. Although the whole NES sequence was exposed to the surface in the reported crystal structure of the Crm1-snurportin 1 complex (10), the partially exposed Flu-A-M1 NES may interact with CRM1 also, as proven by the nuclear export function of the Flu-A-M1 NES under in vivo conditions.
The viral polymerase proteins (PA, PB1, and PB2) are imported into the nucleus to assemble vRNPs, together with NP and viral RNA. NEP and M1 are both required for the nuclear export of vRNPs during the late stage of infection. In a previously reported model of the nuclear export of vRNP, vRNP was exported to the cytoplasm in the form of an NEP-M1-vRNP complex because both NEP and M1 were required. NEP contains an NES, which interacts with CRM1 and mediates the nuclear export activity (30, 32) , while M1 is a candidate adaptor that bridges NEP and vRNPs (38, 39, 47) . The nuclear presence of M1 is required for the nuclear export of vRNPs (8) , perhaps to release the vRNPs from some nuclear components. However, only the nuclear presence of M1 is required for the nuclear export of vRNPs, or only small amounts of M1 were exported to the cytoplasm with vRNP (33) . In the present study, we demonstrated that the NES mutant M1 protein was partially trapped in the nucleus during virus infection and that the nuclear export of vRNP was also impaired by the mutation of the Flu-A-M1 NES. The alanine substitutions of L66 and V68 were within neither the M1 domain bound by NEP nor the domain for vRNP binding (4, 39) , so it seems that the NES-defective M1 protein still bridged the NEP and vRNPs. Taken together with previous reports that NEP was required for the nuclear export of vRNP, we speculate that the NESs of NEP and M1 both participated in the nuclear export of the NEP-M1-vRNP complex.
In the present study, the substitution of L66A and V68A im-paired the function of the Flu-A-M1 NES and lowered the efficiency of the nuclear export of M1 and vRNP during infection, reducing the amount of cytoplasmic M1 and vRNP, which likely resulted in a lower viral assembly efficiency and less virions budding from the infected cells and therefore lowered the growth rate of the mutant virus.
